Pretreatment tumor volume estimation based on total serum PSA in patients with localized prostate cancer

Clinics

Volumn 63, Issue 6, 2008, Pages 759-762

  Kato, Raphael Barroso ^a   Srougi, Victor ^a   Salvadori, Fernanda Aburesi ^a   Ayres, Pedro Paulo Marino Rodrigues ^a   Leite, Katia Moreira ^a   Srougi, Miguel ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Prognosis; Prostate cancer; Prostate specific antigen; Radical prostatectomy; Tumor volume

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; BLOOD; CANCER STAGING; HUMAN; MALE; MIDDLE AGED; PATHOLOGY; PREDICTION AND FORECASTING; PROSTATE TUMOR; PROSTATECTOMY; REGRESSION ANALYSIS; RETROSPECTIVE STUDY;

ADENOCARCINOMA; ADULT; AGED; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES;

EID: 57349193548     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322008000600009     Document Type: Article

References (17)

1. Hering FL, Srougi M. Urologia: Diagnóstico e tratamento. São Paulo. 1998; vol.1, p. 363.
2. Stamey TA, McNeal JE, Yemoto CM, Sigal BM, Johnstone IM. Biological determinants of cancer progression in men with prostate cancer. JAMA. 1999;281:1395-1400.
3. Stamey TA, McNeal JE, Freiha FS, Redwine E. Morphometric and clinical studies on 68 consecutive radical prostatectomies. J Urol. 1988;139:1235-41.
4. Babaian RJ, Troncoso P, Steelhammer LC, Lloreta-Trull J, Ramirez EI. Tumor volume and prostate specific antigen: implications for early detection and defining a window of curability. J Urol. 1995;154:1808-12.
5. Bostwick DG and Choi C. Prognostic factors in early prostate cancer. In: Urology Annual (ed.). New York, WW Norton. 1992; vol 6, pp. 66-101.
6. Blackwell KL, Bostwick DG, Myers RP, Zincke H, Oesterling JE. Combining prostate specific antigen with cancer and gland volume to predict more reliably pathological stage: The influence of prostate specific antigen cancer density. J Urol. 1994;151:1565-70.
7. Bostwick DG and Foster CS. Examination in radical prostatectomy specimens: therapeutic and prognostic significance. In: Pathology of Prostate. Philadelphia, WB Saunders. 1998; vol 34, p. 172.
8. Humphrey PA and Vollmer RT: Intraglandular tumor extent and prognosis in prostatic carcinoma: aplication of a grid method to prostatectomy specimens. Hum Pathol. 1990;21:799-804.
9. Klee GG, Dodge LA, Zincke H, Oesterling JE. Measurement of serum prostate specific antigen using the IMx prostate specific antigen assay. J Urol. 1994;151:94-8.
10. Antunes AA, Freire Gde C, Aiello Filho D, Cury J, Srougi M. Analysis of the risk factors for incidental carcinoma of the prostate in patients with benign prostatic hyperplasia. Clinics. 2006;61:545-50
11. Bostwick DG, Graham SD, Napalkov P, Abrahamsson PA, Sant'Agnese PA, Algaba F et al: Staging of early prostate cancer: a proposed tumor volume-based prognostic index. Urology. 1993; 41:403-11.
12. Carter HB, Partin AW, Epstein JI, Chan DW, Walsh PC. The relationship of prostate specific antigen levels and residual tumor volume in stage A prostate cancer. J Urol. 1990;144:1167-70.
13. Stamey TA, Yang N, Hay AR, McNeal JE, Freiha FS and Redwine E. Prostate-specific antigen as a serum marker for adenocarcinoma of the prostate. N Engl J Med. 1987;317:909-16.
14. Partin AW, Epstein JI, Cho KR, Gitttelsohn AM, Walsh PC. Morphometric measurent of tumor volume and per cent of gland involvement as predictors of pathological stage in clinical stage B prostate cancer. J Urol. 1989;141:341-45.
15. Epstein JI, Carmichael M, Partin AL, Walsh PC. Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of prostate with 5 years of followup. J Urol. 1993;149:1478-81.
16. Carvalhal GF, Humphrey PA, Thorson P, Yan Y, Ramos CG, Catalona WJ. Visual estimate of the percentage of carcinoma is an independent predictor of prostate carcinoma recurrence after radical prostatectomy. Cancer. 2000;89:6:1308-14.
17. McNeal JE, Villers AA, Redwine EA, Freiha FS and Stamey TA. Histological differentiation, cancer volume, and pelvic lymph node metastasis in adenocarcinoma of the prostate. Cancer. 1990;66:1225-33.